Single Use Bioprocessing Market Regional Analysis

Globally, North America dominated the single use bioprocessing market and accounted for a healthy market share in 2021 and is expected to maintain its dominance throughout the forecast period. The rising biopharmaceutical research & development activities and large presence of international market players such as Thermo Fisher Scientific Inc., Danaher Corporation, and G&G Technologies in the region are the major factors projected to drive the growth of the market over the coming years. For instance, in January 2021, Fujifilm Diosynth invested an amount of USD 2 billion in its United States sites for the expansion of its cell culture production in the country.

Furthermore, Asia Pacific is witnessing fastest CAGR during the forecast period due to the rising usage and adoption of biopharmaceuticals in countries including India, China, and Japan. In addition, growing investment b key market players of biotechnology and pharmaceutical companies in the region for the development and enhancement of manufacturing process is further anticipated to drive the growth of the single use bioprocessing market in the coming years.